JP2025518274A5 - - Google Patents

Info

Publication number
JP2025518274A5
JP2025518274A5 JP2024570947A JP2024570947A JP2025518274A5 JP 2025518274 A5 JP2025518274 A5 JP 2025518274A5 JP 2024570947 A JP2024570947 A JP 2024570947A JP 2024570947 A JP2024570947 A JP 2024570947A JP 2025518274 A5 JP2025518274 A5 JP 2025518274A5
Authority
JP
Japan
Prior art keywords
freeze
tetrahydrofolate
methylene
disodium salt
dried composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024570947A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518274A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/064972 external-priority patent/WO2023237484A1/en
Publication of JP2025518274A publication Critical patent/JP2025518274A/ja
Publication of JP2025518274A5 publication Critical patent/JP2025518274A5/ja
Pending legal-status Critical Current

Links

JP2024570947A 2022-06-08 2023-06-05 5,10-メチレン-(6r)-テトラヒドロ葉酸二ナトリウムを含む組成物 Pending JP2025518274A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22177932 2022-06-08
EP22177932.5 2022-06-08
PCT/EP2023/064972 WO2023237484A1 (en) 2022-06-08 2023-06-05 Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate

Publications (2)

Publication Number Publication Date
JP2025518274A JP2025518274A (ja) 2025-06-12
JP2025518274A5 true JP2025518274A5 (enExample) 2025-12-18

Family

ID=81984853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024570947A Pending JP2025518274A (ja) 2022-06-08 2023-06-05 5,10-メチレン-(6r)-テトラヒドロ葉酸二ナトリウムを含む組成物

Country Status (9)

Country Link
US (1) US20250360135A1 (enExample)
EP (2) EP4536187B1 (enExample)
JP (1) JP2025518274A (enExample)
KR (1) KR20250022145A (enExample)
CN (1) CN119365186A (enExample)
AU (1) AU2023282347A1 (enExample)
CA (1) CA3258734A1 (enExample)
IL (1) IL317395A (enExample)
WO (1) WO2023237484A1 (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3483475D1 (de) 1983-05-20 1990-11-29 Bengt Gustavsson Anordnung zur uebertragung einer substanz.
CH682664A5 (en) * 1991-10-15 1993-10-29 Eprova Ag Stable salts of 5,10-methylene tetrahydrofolate.
WO1997027764A1 (en) * 1996-01-31 1997-08-07 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
CH696628A5 (de) * 2002-02-26 2007-08-31 Eprova Ag Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
CH697021A5 (de) * 2003-06-26 2008-03-31 Merck Eprova Ag Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat.
EP1968551A2 (en) * 2005-12-02 2008-09-17 Adventrx Pharmaceuticals, Inc. Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
JP6235779B2 (ja) * 2012-03-28 2017-11-22 株式会社コーセー 葉酸含有組成物及び葉酸の安定化方法
EP2799061A1 (en) * 2013-04-30 2014-11-05 Aprofol AG Stable high dose pharmaceutical composition containing folates
EP2837631A1 (en) 2013-08-14 2015-02-18 Merck & Cie New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid
US10059710B2 (en) 2016-02-17 2018-08-28 Merck & Cie Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
JP7232815B2 (ja) * 2017-08-16 2023-03-03 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 5,10-メチレン-(6r)-テトラヒドロ葉酸を含む安定な凍結乾燥物
CN107892692A (zh) * 2017-12-28 2018-04-10 华东理工大学 (6s)‑5‑甲基四氢叶酸锌盐的制备方法及其应用

Similar Documents

Publication Publication Date Title
JP2003528798A (ja) 銅塩、四級アンモニウム化合物及び過酸化物を含有する、動物の蹄の感染症治療用殺菌組成物
JP2002524398A (ja) 安定化二部型消毒系ならびにそれに関連した組成物および方法
RU2012147527A (ru) Тетрациклиновая композиция
JPH0356418A (ja) 冷蔵庫温度で安定なホリニン酸塩水溶液並びにその製造方法
EP2659894A1 (en) Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate
DE04007657T1 (de) Pharmazeutische Zusammensetzung aus fibrinolytischem Mittel
US20040170701A1 (en) Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection
JPS6372626A (ja) 薬学的組成物
US7863326B2 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superinfections and fungal recurrences
JP2025518274A5 (enExample)
JP6629877B2 (ja) 鼻粘膜投与用医薬組成物
JP4757970B2 (ja) 点眼剤組成物
JP2002114711A (ja) 外用剤組成物
JPH09502709A (ja) エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
EP4223313A1 (en) Pharmaceutical composition comprising acid-base neutralization combination and application thereof
KR20100029829A (ko) 텔비부딘을 함유하는 경구 제약 용액제
KR102850786B1 (ko) 아르기닌 분말 조성물, 이의 제조방법 및 이를 포함하는 영양 보조 식품
JPH09510989A (ja) 安定なフォリン酸塩水溶液
US5075295A (en) Novel oxytetracycline compositions
IL317395A (en) Compositions containing disodium 10,5-methylene-(6R)-tetrahydrofolate
JPH10338638A (ja) 損傷皮膚修復用製剤
KR102316819B1 (ko) 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
JP2000044469A (ja) 内服液剤
JPH06505749A (ja) 1,4−置換ピペリジンの誘導体に基づく新規液体組成物
JP2023525565A5 (enExample)